McLaren Macomb, part of statewide Karmanos Cancer Institute and a regional leader in cancer care and screening procedures, has enhanced its capabilities to assess patients’ risk for developing breast and other common cancers with the addition of Volpara® Risk Pathways.
An industry-leading software program, Volpara determines patients’ individual and unique risk for cancers and manages their care to ensure they receive the appropriate level of timely care.
Volpara will be available to patients through the McLaren Macomb Breast Centers at its four locations throughout Macomb County.
“The importance of early cancer detection cannot be overstated,” said Pat Keigher, McLaren Macomb Regional Director of Cancer Services. “It is not only about finding this disease early, but it’s also about giving the patient a fighting chance for hope, and makes recovery a true possibility. Adding Volpara gives our patients and providers greater ability to identify patients most at-risk for breast cancer and connecting them with the level of care their condition needs.”
Patients serve a crucial role in their risk assessment by providing details about personal and family history. Volpara uses an easy-to-access digital health questionnaires for patients to complete in their homes at their convenience. Using the information provided, clinical teams can identify high-risk patients with the application of risk models and clinical guidelines, and those patients can be directed to follow-up care, such as mammograms, ultrasounds, and breast MRIs.
During their lifetime, one in eight women will be diagnosed with breast cancer, making it critical for women to receive not only regular mammography screenings but also to discuss their personal risk for developing breast cancer with their provider, who may recommend additional screenings or care.
Volpara also facilitates convenient integration with leading genetic labs. If the need for genetic testing or other follow-up care has been determined, the software allows providers to track patients’ progress, update their risk profiles, and generate additional communications, including educational and medical necessity materials.
Make an appointment with a McLaren Macomb primary care provider to discuss and determine breast cancer risk at mclaren.org/appointments.
Learn more about the cancer care capabilities at the Karmanos Cancer Institute at McLaren Macomb at mclaren.org/macombcancer.
About McLaren Macomb
McLaren Macomb is a 288-bed acute care hospital located in Mount Clemens, Mich. More than 400 physicians and nearly 2,000 employees work at McLaren Macomb making it one of Macomb County’s top employers. McLaren Macomb provides a full range of services, including cancer, surgical services, orthopedics and cardiovascular care. As Macomb County’s first verified trauma center, the hospital operates the busiest emergency department in Macomb County. It is also an accredited chest pain center, a certified primary stroke center and an accredited bariatric and metabolic center. McLaren Macomb is a leader in graduate medical education, offering nine residency programs and three fellowship programs. McLaren Macomb has a rich history of providing high quality, compassionate health care and holds a strong position in the community it serves. Learn more at mclaren.org/macomb.
About McLaren Health Care
McLaren Health Care, headquartered in Grand Blanc, Michigan, is a $7.3 billion, fully integrated health care delivery system committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 12 hospitals in Michigan, ambulatory surgery centers, imaging centers, a 640-member employed primary and specialty care physician network, commercial and Medicaid HMOs covering more than 732,838 lives in Michigan and Indiana, home health, infusion and hospice providers, pharmacy services, a clinical laboratory network and a wholly owned medical malpractice insurance company. McLaren operates Michigan’s largest network of cancer centers and providers, anchored by the Karmanos Cancer Institute, a National Cancer Institute-designated comprehensive cancer center. McLaren has 28,000 full-, part-time and contracted employees and more than 113,000 network providers throughout Michigan, Indiana, and Ohio. Learn more at mclaren.org.